Recruitment Manoeuvres in Critically Ill Patients
Launched by UNIVERSITY OF OXFORD · Aug 17, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Recruitment Manoeuvres in Critically Ill Patients," aims to understand how a specific procedure can help patients with severe lung problems who are on mechanical ventilation in the Intensive Care Unit (ICU). When the lungs aren't working properly, doctors sometimes use a technique called a recruitment manoeuvre, which involves inflating the lungs to reopen collapsed areas. However, it’s not always clear how this affects the heart and lungs, and the researchers want to find out which patients might benefit the most from this procedure.
To be eligible for the trial, participants need to be at least 18 years old, be receiving mechanical ventilation through a tube in their throat, and be in the ICU for respiratory failure. Those receiving end-of-life care or who cannot communicate well due to language barriers might not be included. If someone participates, they can expect to have their lung function monitored throughout the day, and doctors will evaluate how effective the recruitment manoeuvre is for them. By learning more about this procedure, the researchers hope to improve care for critically ill patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female, aged 18 years or above
- • Receiving mechanical ventilation for respiratory failure via an endotracheal tube on ICU
- Exclusion Criteria:
- • Consultee indicates patient would be likely to decline enrolment
- • Patient is receiving palliative care
- • Language barriers prevent sufficiently good communication with patient or consultee for full consent to be obtained
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reading, , United Kingdom
Patients applied
Trial Officials
Peter A Robbins, MBBS MA PhD
Study Director
University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials